Wikidata entity: Q419995
C₆H₈ClN₇O (P274)
Quantities
| P4250 | defined daily dose | 10 |
| P2067 | mass | 229.048 |
| P233 | canonical SMILES | String | C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N | ??? |
| P373 | Commons category | String | Amiloride | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C1(=C(N=C(C(=N1)Cl)N)N)/C(=N/C(=N)N)/O | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284515 (LiverTox toxicity likelihood category D) | LiverTox toxicity likelihood category D |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q178194 (cystic fibrosis) | cystic fibrosis |
| P2175 | medical condition treated | ... | Q486485 (anasarka) | anasarka |
| P2175 | medical condition treated | ... | Q1124286 (polyuria) | polyuria |
| P2175 | medical condition treated | ... | Q794086 (hypokalemia) | hypokalemia |
| P2175 | medical condition treated | ... | Q2892779 (nephrogenic diabetes insipidus) | nephrogenic diabetes insipidus |
| P2175 | medical condition treated | ... | Q19000661 (congestive heart failure) | congestive heart failure |
| P361 | part of | ... | Q21422712 (amiloride transport) | amiloride transport |
| P361 | part of | ... | Q22273334 (response to amiloride) | response to amiloride |
| P361 | part of | ... | Q22273335 (cellular response to amiloride) | cellular response to amiloride |
| P361 | part of | ... | Q22324619 (amiloride transmembrane transporter activity) | amiloride transmembrane transporter activity |
| P361 | part of | ... | Q22324620 (amiloride:proton antiporter activity) | amiloride:proton antiporter activity |
| P129 | physically interacts with | ... | Q7671473 (Transient receptor potential cation channel subfamily C member 7) | Transient receptor potential cation channel subfamily C member 7 |
| P129 | physically interacts with | ... | Q7671497 (Transient receptor potential cation channel subfamily V member 2) | Transient receptor potential cation channel subfamily V member 2 |
| P129 | physically interacts with | ... | Q14914580 (Transient receptor potential cation channel, subfamily C, member 6) | Transient receptor potential cation channel, subfamily C, member 6 |
| P129 | physically interacts with | ... | Q15323278 (Transient receptor potential cation channel, subfamily A, member 1) | Transient receptor potential cation channel, subfamily A, member 1 |
| P129 | physically interacts with | ... | Q21102075 (Acid sensing ion channel subunit 1) | Acid sensing ion channel subunit 1 |
| P129 | physically interacts with | ... | Q21102082 (Acid sensing ion channel subunit 2) | Acid sensing ion channel subunit 2 |
| P129 | physically interacts with | ... | Q21102111 (Acid sensing ion channel subunit 3) | Acid sensing ion channel subunit 3 |
| P129 | physically interacts with | ... | Q21123416 (Solute carrier family 9 member A5) | Solute carrier family 9 member A5 |
| P129 | physically interacts with | ... | Q21126833 (Polycystin 2 like 1, transient receptor potential cation channel) | Polycystin 2 like 1, transient receptor potential cation channel |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q155472 (valsartan) | valsartan |
| P769 | significant drug interaction | ... | Q221520 (triamterene) | triamterene |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q277785 (perindopril) | perindopril |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q410074 (losartan) | losartan |
| P769 | significant drug interaction | ... | Q415970 (candesartan) | candesartan |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q421119 (captopril) | captopril |
| P769 | significant drug interaction | ... | Q422185 (enalapril) | enalapril |
| P769 | significant drug interaction | ... | Q422665 (trimethoprim) | trimethoprim |
| P769 | significant drug interaction | ... | Q423804 (eplerenone) | eplerenone |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q412666 (ramipril) | ramipril |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q596022 (quinapril) | quinapril |
| P769 | significant drug interaction | ... | Q733186 (telmisartan) | telmisartan |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q47495698 (lisinopril dihydrate) | lisinopril dihydrate |
| P769 | significant drug interaction | ... | Q929420 (trandolapril) | trandolapril |
| P769 | significant drug interaction | ... | Q947266 (irbesartan) | irbesartan |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P9989 | stylized name | String | aMILoride | ??? |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q200656 (diuretic) | diuretic |
| P2868 | subject has role | ... | Q50430453 (Acid Sensing Ion Channel Blockers) | Acid Sensing Ion Channel Blockers |
| P2868 | subject has role | ... | Q50430455 (epithelial sodium channel blockers) | epithelial sodium channel blockers |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | amiloride | ??? |
Why not click here or view trends?
log id: 1659492